noodls browser compatibility check

The security settings of your browser are blocking the execution of scripts.

To use noodls, javascript support must be enabled. Please change your browser's security settings to enable javascript.

If you have changed your browser's security settings, you can click here.

related announcements

News

Kymera Therapeutics Inc.

Notice of Proposed Sale of Securities (Form 144)
Tekedia Capital LLC

2026; The Year of Elections and Political Realignment with Geopolitical[...]
Kymera Therapeutics Inc.

Notice of Proposed Sale of Securities (Form 144)

Healthcare

Claritev Corporation

06/22/2026 | Press release | Distributed by Public on 06/22/2026 14:02

Regulation FD Disclosure (Form 8-K)

Item 7.01 Regulation FD Disclosure

As stated in the Form 8-K filed on May 18, 2026, in August 2024 Claritev Corporation (the "Company") received a confidential grand jury subpoena issued by the Antitrust Division of the Department of Justice ("DOJ") in connection with an investigation regarding health insurance. On June 17, 2026, the Antitrust Division informed the Company that this antitrust grand jury proceeding is being brought to a close and that the Company is not under any criminal investigation. We welcome the closure and continue to stand by our position that our solutions and data platform comply with antitrust laws. On May 19, 2026, the Company received a civil investigative demand from the Antitrust Division and is cooperating fully with the DOJ in responding to the information requested. The Company remains focused on working with clients, partners and employers across the entire healthcare ecosystem to make healthcare more transparent, accessible, and affordable for all consumers.

The Company is furnishing the information in this Item 7.01 of this Current Report on Form 8-K to comply with Regulation FD. Such information shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed to be incorporated by reference into any of the Company's filings under the Securities Act of 1933, as amended, or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except to the extent expressly set forth by specific reference in such a filing.

Claritev Corporation published this content on June 22, 2026, and is solely responsible for the information contained herein. Distributed via EDGAR on June 22, 2026 at 20:02 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]